Carteolol hydrochloride

Carteolol hydrochloride (OPC-1085 hydrochloride) is a non-selective beta blocker used to treat glaucoma.

Product Specifications

CAS Number

[51781-21-6]

Product Name Alternative

OPC-1085 hydrochloride

UNSPSC

12352005

Hazard Statement

H302

Target

Adrenergic Receptor

Type

Reference compound

Related Pathways

GPCR/G Protein; Neuronal Signaling

Applications

COVID-19-immunoregulation

Field of Research

Cardiovascular Disease; Endocrinology

Assay Protocol

https://www.medchemexpress.com/Carteolol-hydrochloride.html

Concentration

10mM

Purity

99.96

Solubility

DMSO : 50 mg/mL (ultrasonic; warming; heat to 60°C) |H2O : ≥ 25 mg/mL

Smiles

O=C1NC2=C(C(OCC(O)CNC(C)(C)C)=CC=C2)CC1.Cl

Molecular Formula

C16H25ClN2O3

Molecular Weight

328.83

Precautions

H302

References & Citations

[1]Kuwahara, K., et al., Carteolol hydrochloride protects human corneal epithelial cells from UVB-induced damage in vitro. Cornea, 2005. 24 (2) : p. 213-20.|[2]Trinquand, C., et al., [Efficacy and safety of long-acting carteolol 1% once daily. A double-masked, randomized study]. J Fr Ophtalmol, 2003. 26 (2) : p. 131-6.